ACIPX | VMVAX | ACIPX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 13 years | - |
Gain YTD | 13.921 | 18.476 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.56B | 30.9B | 28% |
Annual Yield % from dividends | 2.55 | 2.14 | 119% |
Returns for 1 year | 19.01 | 28.30 | 67% |
Returns for 3 years | N/A | 14.98 | - |
Returns for 5 years | N/A | 48.86 | - |
Returns for 10 years | N/A | 100.72 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSLLX | 22.58 | N/A | N/A |
Goldman Sachs Enh Core Eq Fund-InvShares | |||
FGIUX | 40.60 | -0.05 | -0.12% |
Fidelity Advisor Growth & Income C | |||
RGAEX | 80.98 | -0.15 | -0.18% |
American Funds Growth Fund of Amer R4 | |||
DPRCX | 12.16 | -0.04 | -0.33% |
Delaware Global Listed Real Assets C | |||
USBOX | 24.85 | -0.10 | -0.40% |
Pear Tree Quality Ordinary |